Disposition of 200000000 shares by Emil Assentato of Nukkleus subject to Rule 16b-3

NUKK Stock  USD 15.70  1.62  11.51%   
About 54% of Nukkleus' institutional investors are presently thinking to get in. The analysis of the overall prospects from investing in Nukkleus suggests that some traders are, at the present time, interested. Nukkleus' investing sentiment shows overall attitude of investors towards Nukkleus.
  
Filed transaction by Nukkleus Director, 10 Percent Owner, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Nukkleus insider trading alert for disposition of common stock, $0.0001 par value per share by Emil Assentato, Director, 10 Percent Owner, Officer: Chief Executive Officer, on 28th of July 2024. This event was filed by Nukkleus with SEC on 2023-11-20. Statement of changes in beneficial ownership - SEC Form 4. Emil Assentato currently serves as president ceo, treasurer, secretary, director of Nukkleus

Cash Flow Correlation

Nukkleus' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Nukkleus' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Nukkleus Fundamental Analysis

We analyze Nukkleus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nukkleus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nukkleus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Nukkleus is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Nukkleus Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nukkleus stock to make a market-neutral strategy. Peer analysis of Nukkleus could also be used in its relative valuation, which is a method of valuing Nukkleus by comparing valuation metrics with similar companies.
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out Nukkleus Hype Analysis, Nukkleus Correlation and Nukkleus Performance.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(39.44)
Revenue Per Share
3.422
Quarterly Revenue Growth
(0.95)
Return On Assets
(3.97)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.